The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

Anne E. Burke

doi:10.1016/j.ajog.2011.04.033

The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

Anne E. Burke

School of Medicine

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

Original language	English (US)
Pages (from-to)	S14-S17
Journal	American journal of obstetrics and gynecology
Volume	205
Issue number	4 SUPPL.
DOIs	https://doi.org/10.1016/j.ajog.2011.04.033
State	Published - Oct 2011

Keywords

emergency contraception
etonogestrel
levonorgestrel
medroxyprogesterone acetate
norethindrone

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/j.ajog.2011.04.033

Cite this

@article{b124c3c816fa4b948cba5d28d2e82aca,

title = "The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives",

abstract = "The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.",

keywords = "emergency contraception, etonogestrel, levonorgestrel, medroxyprogesterone acetate, norethindrone",

author = "Burke, {Anne E.}",

year = "2011",

month = oct,

doi = "10.1016/j.ajog.2011.04.033",

language = "English (US)",

volume = "205",

pages = "S14--S17",

journal = "American journal of obstetrics and gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "4 SUPPL.",

}

TY - JOUR

T1 - The state of hormonal contraception today

T2 - Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

AU - Burke, Anne E.

PY - 2011/10

Y1 - 2011/10

N2 - The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

AB - The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

KW - emergency contraception

KW - etonogestrel

KW - levonorgestrel

KW - medroxyprogesterone acetate

KW - norethindrone

UR - http://www.scopus.com/inward/record.url?scp=80053341759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053341759&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2011.04.033

DO - 10.1016/j.ajog.2011.04.033

M3 - Review article

C2 - 21961819

AN - SCOPUS:80053341759

SN - 0002-9378

VL - 205

SP - S14-S17

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

IS - 4 SUPPL.

ER -

The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this